ABBV vs CEG: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Constellation Energy Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-08-06.
AbbVie Inc. · Healthcare
$261.07
+1.2% upside to fair value
Grade C
High Quality
VS
Constellation Energy Corporation · Utilities
$265.12
+11.3% upside to fair value
Med Conviction
Grade B-
QuantHub Verdict
CEG has more upside to fair value
(+11.3%).
CEG trades at a lower forward P/E
(22.6x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
CEG |
| Current Price |
$261.07 |
$265.12 |
| Fair Value Estimate |
$264.30 |
$295.00 |
| Upside to Fair Value |
+1.2%
|
+11.3%
|
| Market Cap |
$461.3B |
$95.2B |
| Forward P/E |
128.0x
|
22.6x
|
| EV / EBITDA |
31.0x
|
12.6x
|
| Price / Sales |
7.3x
|
2.9x
|
| Price / FCF |
22.1x
|
196.2x
|
| Revenue Growth YoY |
+12.4%
|
+35.3%
|
| Gross Margin |
70.7%
|
44.6%
|
| Operating Margin |
27.6%
|
14.6%
|
| Return on Equity |
68.0%
|
11.1%
|
| Dividend Yield |
0% |
0.64% |
| FCF Yield |
4.52%
|
0.51%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
AbbVie Inc. is a leading healthcare company specializing in drug manufacturing with a strong focus on immunology and aesthetics. The company is transitioning from its historical Humira dominance, which has faced loss of exclusivity, toward high-growth assets like Skyrizi and Rinvoq that are driving robust revenue growth of 12.4% in the most recent quarter. Despite strong revenue growth and a dura…
Constellation Energy is the largest private-sector power producer in the world and the largest operator of nuclear plants in the United States, controlling roughly 32,400 megawatts of largely carbon-free generation before its January 2026 acquisition of Calpine added about 23 gigawatts of natural gas and geothermal capacity to create a nearly 60 gigawatt platform spanning nuclear, gas, wind, sola…
Accumulation Zones
| Metric |
ABBV |
CEG |
| Zone Low |
$198.23 |
$221.00 |
| Zone High |
$224.66 |
$251.00 |
| In Buy Zone? |
No
|
No
|